ROIV Sale Disclosure
Venker Eric · SEC Form 4 · Filed Oct 22, 2026
Sale
Calculated transaction value
$6.52M
Venker Eric President & Immunovant CEO
ROIV
Roivant Sciences Ltd
ROIV
Transaction date
Oct 20, 2026
Public filing date
Oct 22, 2026
Filing lag
Filed 2 days later
ROIV daily price context
Close on/before transaction
$34.92
Oct 20, 2026
First close after public filing
$36.49
Oct 23, 2026
Return after filing · so far
+11.46%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 185,856 shares @ $35.09
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001635088-26-000116
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$7.02M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Roivant Sciences Ltd. ROIV Current | Sale | Oct 20, 2026 | $6.52M |
| Roivant Sciences Ltd. ROIV | Sale | Oct 20, 2026 | $500.98K |